Immune Checkpoint Inhibition in Prostate Cancer

Although immunotherapy has proved to be effective in a variety of cancer subtypes, the role of immune checkpoint inhibition in the treatment of prostate cancer remains unclear. Here we review results from the latest clinical trials and discuss data suggesting that certain genetic mutations may confer increased sensitivity to immune checkpoint blockade. Although immunotherapy has proved to be effective in a variety of cancer subtypes, the role of...